Open Access

REVIEW

Transcatheter Pulmonary Valve Implantation: A State of the Art Review

by Biagio Castaldi^1,*, Francesco Prati¹, Alice Pozza^1,2, Irene Cattapan^1,2, Jennifer Fumanelli^1,2, Domenico Sirico¹, Giovanni Di Salvo¹

1 Paediatric Cardiology Unit, Department of Women’s and Child’s Health, University of Padua, Padua, 35129, Italy
2 PhD School in Developmental Medicine and Health Planning Sciences, University of Padua, Padua, 35129, Italy

* Corresponding Author: Biagio Castaldi. Email:

Congenital Heart Disease 2024, 19(5), 513-533. https://doi.org/10.32604/chd.2025.058053

Received 03 September 2024; Accepted 17 December 2024; Issue published 31 December 2024

Abstract

Congenital heart disease (CHD) affects about 1% of live births. Among them, about 20% will undergo one or more surgical or percutaneous maneuvers on the right ventricle outflow tract or pulmonary valve. Transcatheter pulmonary valve implantation is a recently available less invasive alternative to surgery for treatment of right ventricular outflow tract dysfunction. Thus, residual dysfunction can be treated early and with a lower risk profile. This narrative review aimed to describe the state of the art of percutaneous pulmonary valve implantation.

---

Keywords

---